Intra-Cellular Therapies Inc. (ITCI) NASDAQ

$47.52 -1.40 (-2.86%)

Market Cap: $4.63B

As of 02/06/23 04:00 PM EST. Market closed.

(ITCI)

Intra-Cellular Therapies Inc. (ITCI) NASDAQ

$47.52 -1.40 (-2.86%)

Market Cap: $4.63B

As of 02/06/23 04:00 PM EST. Market closed.

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic ... read more

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sharon Mates
Full Time Employees
512
CEO Compensation (Base)
$722,800
CEO Compensation (Total)
$4.48M
URL
Address
430 E 29th St, New York, New York, 10016-8367.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sharon Mates
Full Time Employees
512
CEO Compensation (Base)
$722,800
CEO Compensation (Total)
$4.48M
Address
430 E 29th St, New York, New York, 10016-8367.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$48.99
Previous Close
$48.92
Days Range
$47.26 - $49.54
52 week range
$42.42 - $66
Volume
415,667
Avg. Volume (30 days)
615,100
Market Cap
$4.63B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
94,705,054
Open
$48.99
Previous Close
$48.92
Days Range
$47.26 - $49.54
52 week range
$42.42 - $66
Volume
415,667
Avg. Volume (30 days)
615,100
Market Cap
$4.63B
Dividend Yield
0.00%
P/E
-
Shares Outstanding
94,705,054

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INTRA-CELLULAR THERAPIES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
VAN NOSTRAND ROBERT LDirectorDec 30, 2022 Option Exercise$52.92975,1339,250Jan 03, 2023, 04:19 PM
RIGGS RORY BDirectorDec 30, 2022 Option Exercise$52.9232116,98778,047Jan 03, 2023, 04:18 PM
MARCUS JOEL SDirectorDec 19, 2022 Sale$50.825,000254,10029,233Dec 21, 2022, 04:06 PM
Mates SharonChairman, President & CEODec 13, 2022 Sale$55.0033,0831,819,5651,100,309Dec 15, 2022, 07:01 PM
Halstead MichaelEVP and General CounselDec 01, 2022 Option Exercise$15.4750,000773,50050,000Dec 02, 2022, 07:14 PM
Halstead MichaelEVP and General CounselDec 01, 2022 Sale$53.7350,0002,686,51422,796Dec 02, 2022, 07:14 PM
MARCUS JOEL SDirectorNov 07, 2022 Sale$52.3010,000523,02339,233Nov 08, 2022, 04:12 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2022 Option Exercise$46.531105,1189,153Oct 05, 2022, 04:04 PM
RIGGS RORY BDirectorSep 30, 2022 Option Exercise$46.5336516,98377,726Oct 04, 2022, 04:11 PM
Hineline Lawrence J.SVP of Finance CFOSep 21, 2022 Option Exercise$15.4765,1641,008,08765,164Sep 23, 2022, 09:01 PM
Hineline Lawrence J.SVP of Finance CFOSep 21, 2022 Sale$45.6365,1642,973,40633,303Sep 23, 2022, 09:01 PM
VAN NOSTRAND ROBERT LDirectorAug 11, 2022 Option Exercise$12.6530,000379,50039,043Aug 12, 2022, 06:09 PM
VAN NOSTRAND ROBERT LDirectorAug 11, 2022 Sale$57.1330,0001,713,97510,543Aug 12, 2022, 06:09 PM
MARCUS JOEL SDirectorAug 11, 2022 Sale$59.2210,000592,20044,233Aug 12, 2022, 06:05 PM
RIGGS RORY BDirectorJun 30, 2022 Option Exercise$57.0828916,49677,361Jul 05, 2022, 04:06 PM
MARCUS JOEL SDirectorMay 12, 2022 Sale$55.0010,000550,00054,233May 13, 2022, 05:24 PM
Neumann MarkEVP, Chief Commercial OfficerApr 08, 2022 Option Exercise$12.7386,3481,099,210131,687Apr 08, 2022, 06:56 PM
Neumann MarkEVP, Chief Commercial OfficerApr 08, 2022 Sale$64.3786,3485,558,051114,211Apr 08, 2022, 06:56 PM
VAN NOSTRAND ROBERT LDirectorMar 31, 2022 Option Exercise$61.191267,7108,935Apr 04, 2022, 04:11 PM
RIGGS RORY BDirectorMar 31, 2022 Option Exercise$61.1925715,72677,072Apr 04, 2022, 04:08 PM
RIGGS RORY BDirectorMar 18, 2022 Sale$61.1820,6371,262,50515,736Mar 18, 2022, 08:12 PM
RIGGS RORY BDirectorMar 17, 2022 Sale$60.33141,4998,536,646135,549Mar 18, 2022, 08:12 PM
RIGGS RORY BDirectorMar 16, 2022 Sale$59.2764,5343,824,827205,984Mar 18, 2022, 08:12 PM
Mates SharonChairman, President & CEOMar 09, 2022 Option Exercise$2.8438,925110,5471,133,392Mar 10, 2022, 04:13 PM
MARCUS JOEL SDirectorMar 08, 2022 Sale$52.6815,000790,15038,980Mar 09, 2022, 09:49 PM
MARCUS JOEL SDirectorMar 07, 2022 Sale$54.525,000272,60043,980Mar 09, 2022, 09:49 PM
Durgam Suresh K.Chief Medical OfficerMar 04, 2022 Sale$55.523,860214,30723,104Mar 04, 2022, 06:05 PM
Durgam Suresh K.Chief Medical OfficerMar 02, 2022 Sale$56.984,177238,00526,964Mar 04, 2022, 06:05 PM
Durgam Suresh K.Chief Medical OfficerFeb 24, 2022 Sale$52.274,046211,46833,984Feb 25, 2022, 07:09 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 24, 2022 Sale$52.217,906412,81050,585Feb 25, 2022, 07:08 PM
Halstead MichaelEVP and General CounselFeb 24, 2022 Sale$51.987,906410,9334,188Feb 25, 2022, 07:06 PM
Hineline Lawrence J.SVP of Finance CFOFeb 24, 2022 Sale$51.977,454387,3494,083Feb 25, 2022, 07:04 PM
Mates SharonChairman, President & CEOFeb 24, 2022 Sale$51.9822,5891,174,0741,105,807Feb 25, 2022, 07:01 PM
Durgam Suresh K.Chief Medical OfficerFeb 22, 2022 Sale$55.294,177230,95828,638Feb 23, 2022, 07:08 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 22, 2022 Sale$55.2911,139615,82749,946Feb 23, 2022, 07:07 PM
Halstead MichaelEVP and General CounselFeb 22, 2022 Sale$55.4011,139617,1004,550Feb 23, 2022, 07:05 PM
Hineline Lawrence J.SVP of Finance CFOFeb 22, 2022 Sale$55.4010,443578,5064,627Feb 23, 2022, 07:02 PM
Mates SharonChairman, President & CEOFeb 22, 2022 Sale$55.3927,8471,542,4131,107,134Feb 23, 2022, 07:00 PM
Durgam Suresh K.Chief Medical OfficerJan 18, 2022 Sale$42.036,223261,55323,104Jan 20, 2022, 04:07 PM
Durgam Suresh K.Chief Medical OfficerJan 10, 2022 Sale$40.766,870280,02034,677Jan 11, 2022, 08:08 PM
Neumann MarkEVP, Chief Commercial OfficerJan 10, 2022 Sale$40.7820,948854,25563,526Jan 11, 2022, 08:06 PM
Halstead MichaelEVP and General CounselJan 10, 2022 Sale$40.7719,639800,77417,135Jan 11, 2022, 08:04 PM
Hineline Lawrence J.SVP of Finance CFOJan 10, 2022 Sale$40.7619,639800,42016,534Jan 11, 2022, 08:02 PM
Mates SharonChairman, President & CEOJan 10, 2022 Sale$40.7841,8961,708,4291,130,559Jan 11, 2022, 08:00 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2021 Option Exercise$52.341487,7468,809Jan 04, 2022, 09:52 PM
RIGGS RORY BDirectorDec 31, 2021 Option Exercise$52.3430015,70276,815Jan 04, 2022, 09:50 PM
Halstead MichaelEVP and General CounselDec 21, 2021 Option Exercise$16.38176,8632,897,494176,863Dec 23, 2021, 07:02 PM
Halstead MichaelEVP and General CounselDec 21, 2021 Sale$47.56176,8638,412,278154,243Dec 23, 2021, 07:02 PM
Hineline Lawrence J.SVP of Finance CFODec 21, 2021 Option Exercise$16.81175,0002,941,951175,000Dec 23, 2021, 07:00 PM
Hineline Lawrence J.SVP of Finance CFODec 21, 2021 Sale$47.59175,0008,328,664149,538Dec 23, 2021, 07:00 PM
Neumann MarkEVP, Chief Commercial OfficerOct 18, 2021 Sale$40.8613,448549,55152,085Oct 19, 2021, 04:26 PM
Mates SharonChairman, President & CEOOct 15, 2021 Option Exercise$2.841,0753,0531,102,659Oct 18, 2021, 06:00 PM
Mates SharonChairman, President & CEOOct 18, 2021 Sale$40.008,192327,6801,094,467Oct 18, 2021, 06:00 PM
Mates SharonChairman, President & CEOOct 15, 2021 Sale$40.0040,3921,615,6801,101,584Oct 18, 2021, 06:00 PM
Mates SharonChairman, President & CEOOct 14, 2021 Sale$40.001,41656,6401,141,976Oct 18, 2021, 06:00 PM
LERNER RICHARD ADirectorSep 30, 2021 Option Exercise$37.2840214,98796,663Oct 04, 2021, 05:43 PM
RIGGS RORY BDirectorSep 30, 2021 Option Exercise$37.2842215,73276,515Oct 04, 2021, 04:24 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2021 Option Exercise$37.282158,0158,661Oct 04, 2021, 04:23 PM
Mates SharonChairman, President & CEOAug 23, 2021 Option Exercise$2.8410,00028,4001,143,392Aug 24, 2021, 04:06 PM
VAN NOSTRAND ROBERT LDirectorJun 30, 2021 Option Exercise$40.821737,0628,446Jul 02, 2021, 04:55 PM
RIGGS RORY BDirectorJun 30, 2021 Option Exercise$40.8238515,71676,093Jul 02, 2021, 04:52 PM
LERNER RICHARD ADirectorJun 30, 2021 Option Exercise$40.8236714,98196,261Jul 02, 2021, 04:47 PM
Alafi Christopher DDirectorMay 24, 2021 Sale$40.4726,5751,075,490142,325May 25, 2021, 06:02 PM
Alafi Christopher DDirectorMay 21, 2021 Sale$40.001,10044,000168,900May 25, 2021, 06:02 PM
LERNER RICHARD ADirectorMar 31, 2021 Option Exercise$33.9344214,99795,894Apr 02, 2021, 05:31 PM
MARCUS JOEL SDirectorMar 02, 2021 Option Exercise$26.5820,000531,60087,519Mar 04, 2021, 05:43 PM
MARCUS JOEL SDirectorMar 02, 2021 Sale$34.9315,250532,68372,269Mar 04, 2021, 05:43 PM
Durgam Suresh K.Chief Medical OfficerFeb 19, 2021 Sale$39.252,734107,31023,304Feb 22, 2021, 08:09 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 19, 2021 Sale$39.225,184203,30845,939Feb 22, 2021, 08:07 PM
Hineline Lawrence J.SVP of Finance CFOFeb 19, 2021 Sale$39.2310,442409,6251,200Feb 22, 2021, 08:05 PM
Halstead MichaelEVP and General CounselFeb 19, 2021 Sale$39.2411,139437,1331,100Feb 22, 2021, 08:03 PM
Mates SharonChairman, President & CEOFeb 19, 2021 Sale$39.2327,8471,092,4361,136,492Feb 22, 2021, 08:01 PM
Durgam Suresh K.Chief Medical OfficerJan 11, 2021 Sale$32.124,367140,25917,584Jan 12, 2021, 07:07 PM
Neumann MarkEVP, Chief Commercial OfficerJan 11, 2021 Sale$32.029,684310,08239,384Jan 12, 2021, 07:06 PM
Hineline Lawrence J.SVP of Finance CFOJan 11, 2021 Sale$32.0219,638628,7692,376Jan 12, 2021, 07:05 PM
Halstead MichaelEVP and General CounselJan 11, 2021 Sale$32.0319,638628,9781,936Jan 12, 2021, 07:03 PM
Mates SharonChairman, President & CEOJan 11, 2021 Sale$32.0141,8961,341,2601,137,977Jan 12, 2021, 07:01 PM
Hineline Lawrence J.SVP of Finance CFOJan 04, 2021 Sale$31.3115,810495,0083,450Jan 05, 2021, 06:13 PM
Halstead MichaelEVP and General CounselJan 04, 2021 Sale$31.3016,160505,8343,174Jan 05, 2021, 06:11 PM
Mates SharonChairman, President & CEOJan 04, 2021 Sale$31.3048,3411,513,2711,153,820Jan 05, 2021, 06:09 PM
LERNER RICHARD ADirectorDec 31, 2020 Option Exercise$31.8047114,97895,452Jan 05, 2021, 06:07 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2020 Option Exercise$31.802227,0608,065Jan 05, 2021, 06:05 PM
RIGGS RORY BDirectorDec 31, 2020 Option Exercise$31.8049515,74161,477Jan 05, 2021, 06:03 PM
Alafi Christopher DDirectorDec 31, 2020 Option Exercise$31.8049515,741346,331Jan 05, 2021, 06:01 PM
Mates SharonChairman, President & CEODec 18, 2020 Option Exercise$2.7434,00093,1601,147,392Dec 21, 2020, 04:03 PM
Halstead MichaelEVP and General CounselNov 17, 2020 Option Exercise$13.8675,0001,039,50079,425Nov 19, 2020, 08:05 PM
Halstead MichaelEVP and General CounselNov 17, 2020 Sale$27.6279,4252,193,4463,761Nov 19, 2020, 08:05 PM
Hineline Lawrence J.SVP of Finance CFONov 11, 2020 Option Exercise$3.0520,00061,00028,034Nov 13, 2020, 05:51 PM
Hineline Lawrence J.SVP of Finance CFONov 11, 2020 Sale$25.4128,034712,3440Nov 13, 2020, 05:51 PM
Mates SharonChairman, President & CEONov 10, 2020 Sale$26.3450,0001,317,1011,132,523Nov 12, 2020, 05:51 PM
Mates SharonChairman, President & CEONov 04, 2020 Sale$25.0050,0001,250,0001,163,392Nov 06, 2020, 06:00 PM
Neumann MarkEVP, Chief Commercial OfficerOct 16, 2020 Sale$26.806,792182,02628,120Oct 16, 2020, 04:04 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2020 Option Exercise$25.662767,0827,843Oct 02, 2020, 04:24 PM
RIGGS RORY BDirectorSep 30, 2020 Option Exercise$25.6661315,73060,982Oct 02, 2020, 04:22 PM
LERNER RICHARD ADirectorSep 30, 2020 Option Exercise$25.6658414,98594,981Oct 02, 2020, 04:17 PM
Alafi Christopher DDirectorSep 30, 2020 Option Exercise$25.6661315,730345,836Oct 02, 2020, 04:13 PM
Alafi Christopher DDirectorSep 14, 2020 Buy$29.6049,5001,465,2004,743,770Sep 14, 2020, 05:03 PM
Hineline Lawrence J.SVP of Finance CFOSep 09, 2020 Option Exercise$12.7326,983343,49450,017Sep 11, 2020, 07:08 PM
Hineline Lawrence J.SVP of Finance CFOSep 09, 2020 Sale$31.1441,9831,307,3518,034Sep 11, 2020, 07:08 PM
Alafi Christopher DDirectorSep 11, 2020 Buy$28.0821,000589,6804,694,270Sep 11, 2020, 04:15 PM
VAN NOSTRAND ROBERT LDirectorJun 30, 2020 Option Exercise$25.672757,0597,567Jul 02, 2020, 07:12 PM
LERNER RICHARD ADirectorJun 30, 2020 Option Exercise$25.6758414,99194,397Jul 02, 2020, 07:05 PM
RIGGS RORY BDirectorJun 30, 2020 Option Exercise$25.6761315,73660,369Jul 02, 2020, 07:02 PM
Alafi Christopher DDirectorJun 30, 2020 Option Exercise$25.6761315,736345,223Jul 02, 2020, 06:58 PM
MARCUS JOEL SDirectorMay 14, 2020 Sale$20.049,602192,42439,140May 15, 2020, 05:37 PM
MARCUS JOEL SDirectorMay 11, 2020 Sale$19.9550,000997,50048,742May 13, 2020, 07:48 PM
MARCUS JOEL SDirectorMay 13, 2020 Sale$20.637,297150,53714,374May 13, 2020, 07:48 PM
LERNER RICHARD ADirectorMay 11, 2020 Option Exercise$2.7425,00068,50097,313May 13, 2020, 05:20 PM
LERNER RICHARD ADirectorMay 11, 2020 Sale$20.503,50071,75093,813May 13, 2020, 05:20 PM
Alafi Christopher DDirectorMar 31, 2020 Option Exercise$15.371,02415,739344,610Apr 02, 2020, 06:05 PM
LERNER RICHARD ADirectorMar 31, 2020 Option Exercise$15.3797514,98672,313Apr 02, 2020, 06:01 PM
VAN NOSTRAND ROBERT LDirectorMar 31, 2020 Option Exercise$15.374607,0707,292Apr 02, 2020, 05:55 PM
RIGGS RORY BDirectorMar 31, 2020 Option Exercise$15.371,02415,73945,751Apr 02, 2020, 05:50 PM
Halstead MichaelEVP and General CounselJan 24, 2020 Option Exercise$23.613,80989,9304,425Jan 28, 2020, 09:31 PM
Hineline Lawrence J.SVP of Finance CFOJan 24, 2020 Option Exercise$23.613,80989,93023,034Jan 28, 2020, 09:30 PM
Mates SharonChairman, President & CEOJan 24, 2020 Option Exercise$23.619,323220,1161,213,392Jan 28, 2020, 09:28 PM
LERNER RICHARD ADirectorDec 31, 2019 Option Exercise$34.3140013,72471,338Jan 16, 2020, 06:13 PM
Satlin AndrewEVP and Chief Medical OfficerJan 09, 2020 Sale$26.1611,573302,75011,338Jan 10, 2020, 09:14 PM
Neumann MarkEVP, Chief Commercial OfficerJan 08, 2020 Option Exercise$26.346,157162,17521,464Jan 10, 2020, 09:11 PM
Mates SharonChairman, President & CEOJan 09, 2020 Sale$26.1641,8951,095,9731,204,707Jan 10, 2020, 09:09 PM
Halstead MichaelEVP and General CounselJan 09, 2020 Sale$26.1619,638513,730191Jan 10, 2020, 09:06 PM
Hineline Lawrence J.SVP of Finance CFOJan 09, 2020 Sale$26.1619,638513,73018,800Jan 10, 2020, 09:03 PM
Mates SharonChairman, President & CEOJan 08, 2020 Option Exercise$2.7460,000164,4001,246,602Jan 08, 2020, 09:11 PM
Mates SharonChairman, President & CEOJan 06, 2020 Sale$30.2845,5981,380,8801,182,366Jan 08, 2020, 09:11 PM
Halstead MichaelEVP and General CounselJan 06, 2020 Sale$30.3421,458651,00717,704Jan 08, 2020, 09:02 PM
Hineline Lawrence J.SVP of Finance CFOJan 06, 2020 Sale$30.2921,458650,00336,391Jan 08, 2020, 09:00 PM
Halstead MichaelEVP and General CounselJan 02, 2020 Sale$32.437,807253,2146,375Jan 03, 2020, 09:17 PM
Hineline Lawrence J.SVP of Finance CFOJan 02, 2020 Sale$32.437,807253,16525,807Jan 03, 2020, 09:16 PM
Mates SharonChairman, President & CEODec 31, 2019 Option Exercise$2.746,00016,4401,162,185Jan 03, 2020, 09:14 PM
Mates SharonChairman, President & CEOJan 02, 2020 Sale$32.4517,478567,2301,158,485Jan 03, 2020, 09:14 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2019 Option Exercise$34.311705,8336,832Jan 03, 2020, 09:13 PM
RIGGS RORY BDirectorDec 31, 2019 Option Exercise$34.3142214,47944,727Jan 03, 2020, 09:12 PM
Alafi Christopher DDirectorDec 31, 2019 Option Exercise$34.3142214,479343,586Jan 03, 2020, 09:11 PM
Hineline Lawrence J.SVP of Finance CFODec 23, 2019 Option Exercise$2.749,60026,30434,832Dec 26, 2019, 04:06 PM
Hineline Lawrence J.SVP of Finance CFODec 23, 2019 Sale$25.5015,032383,31625,232Dec 26, 2019, 04:06 PM
Neumann MarkEVP, Chief Commercial OfficerOct 16, 2019 Sale$8.256,77455,8866,674Oct 17, 2019, 04:50 PM
RIGGS RORY BDirectorSep 30, 2019 Option Exercise$7.471,94114,49944,305Oct 02, 2019, 05:37 PM
LERNER RICHARD ADirectorSep 30, 2019 Option Exercise$7.471,84013,74570,938Oct 02, 2019, 05:35 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2019 Option Exercise$7.477805,8276,662Oct 02, 2019, 05:32 PM
Alafi Christopher DDirectorSep 30, 2019 Option Exercise$7.471,94114,499343,164Oct 02, 2019, 05:29 PM
Alafi Christopher DDirectorSep 10, 2019 Buy$10.26485,0004,974,6784,673,270Sep 11, 2019, 04:30 PM
Alafi Christopher DDirectorAug 30, 2019 Buy$8.52125,0001,065,2124,188,270Sep 04, 2019, 06:24 PM
VAN NOSTRAND ROBERT LDirectorJun 28, 2019 Option Exercise$12.984495,8285,882Jul 02, 2019, 05:17 PM
LERNER RICHARD ADirectorJun 28, 2019 Option Exercise$12.981,05913,74669,098Jul 02, 2019, 05:12 PM
RIGGS RORY BDirectorJun 28, 2019 Option Exercise$12.981,11714,49942,364Jul 02, 2019, 05:03 PM
Alafi Christopher DDirectorJun 28, 2019 Option Exercise$12.981,11714,499341,223Jul 02, 2019, 12:00 AM
Alafi Christopher DDirectorNov 22, 2017 Buy$15.5510,000155,5003,963,270Jun 19, 2019, 05:48 PM
Alafi Christopher DDirectorJun 12, 2019 Buy$11.73170,0001,993,793170,000Jun 14, 2019, 05:23 PM
MARCUS JOEL SDirectorMay 29, 2019 Option Exercise$12.4520,000249,00041,671May 31, 2019, 04:35 PM
Alafi Christopher DDirectorMay 14, 2019 Buy$12.56100,0001,256,3504,053,270May 15, 2019, 06:03 PM
Alafi Christopher DDirectorMar 31, 2019 Option Exercise$12.181,19014,494750,106Apr 02, 2019, 07:03 PM
VAN NOSTRAND ROBERT LDirectorMar 31, 2019 Option Exercise$12.184785,8225,433Apr 02, 2019, 06:59 PM
RIGGS RORY BDirectorMar 31, 2019 Option Exercise$12.181,19014,49441,247Apr 02, 2019, 06:56 PM
LERNER RICHARD ADirectorMar 31, 2019 Option Exercise$12.181,12813,73968,039Apr 02, 2019, 06:52 PM
Hineline Lawrence J.SVP of Finance CFOFeb 27, 2019 Option Exercise$2.7410,40028,49626,232Mar 01, 2019, 07:41 PM
Hineline Lawrence J.SVP of Finance CFOFeb 27, 2019 Sale$15.001,00015,00025,232Mar 01, 2019, 07:41 PM
Mates SharonChairman, President & CEOJan 07, 2019 Sale$12.436,60482,0881,138,707Jan 08, 2019, 09:28 PM
Mates SharonChairman, President & CEOJan 04, 2019 Sale$11.4545,598522,2221,152,850Jan 08, 2019, 09:28 PM
Halstead MichaelEVP and General CounselJan 04, 2019 Sale$11.4621,458245,8178,697Jan 08, 2019, 09:24 PM
Halstead MichaelEVP and General CounselJan 07, 2019 Sale$12.423,10838,601191Jan 08, 2019, 09:24 PM
Hineline Lawrence J.SVP of Finance CFOJan 07, 2019 Sale$12.423,10838,60117,032Jan 08, 2019, 09:21 PM
Hineline Lawrence J.SVP of Finance CFOJan 04, 2019 Sale$11.4521,458245,78221,882Jan 08, 2019, 09:21 PM
Vanover Kimberly E.SVP, Early Stage Clinical Dev.Jan 07, 2019 Sale$12.295927,27627,068Jan 08, 2019, 09:19 PM
Vanover Kimberly E.SVP, Early Stage Clinical Dev.Jan 04, 2019 Sale$11.479,564109,70429,844Jan 08, 2019, 09:19 PM
Davis Robert ESVP, Chief Scientific OfficerJan 04, 2019 Sale$11.469,564109,63046,691Jan 08, 2019, 09:16 PM
Mates SharonChairman, President & CEOJan 02, 2019 Sale$11.0917,478193,8311,138,707Jan 03, 2019, 09:02 PM
Halstead MichaelEVP and General CounselJan 02, 2019 Sale$11.097,80786,580191Jan 03, 2019, 08:58 PM
Vanover Kimberly E.SVP, Early Stage Clinical Dev.Jan 02, 2019 Sale$11.104,83453,65716,861Jan 03, 2019, 08:46 PM
Davis Robert ESVP, Chief Scientific OfficerJan 02, 2019 Sale$11.114,83453,70634,744Jan 03, 2019, 08:42 PM
Hineline Lawrence J.SVP of Finance CFOJan 02, 2019 Sale$11.097,80786,58017,032Jan 03, 2019, 08:23 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2018 Option Exercise$11.395125,8324,955Jan 03, 2019, 08:19 PM
RIGGS RORY BDirectorDec 31, 2018 Option Exercise$11.391,27314,49940,057Jan 03, 2019, 08:15 PM
LERNER RICHARD ADirectorDec 31, 2018 Option Exercise$11.391,20713,74811,430Jan 03, 2019, 08:11 PM
Alafi Christopher DDirectorDec 31, 2018 Option Exercise$11.391,27314,499748,916Jan 03, 2019, 08:05 PM
Mates SharonChairman, President & CEODec 10, 2018 Option Exercise$1.5050,00075,0001,138,707Dec 11, 2018, 05:55 PM
Davis Robert ESVP, Chief Scientific OfficerDec 06, 2018 Sale$13.5389912,16330,256Dec 07, 2018, 04:44 PM
MARCUS JOEL SDirectorNov 12, 2018 Sale$17.947,000125,58078,742Nov 13, 2018, 05:34 PM
MARCUS JOEL SDirectorNov 09, 2018 Sale$18.2425,000456,00085,742Nov 13, 2018, 05:34 PM
LERNER RICHARD ADirectorOct 22, 2018 Option Exercise$1.5012,50018,75066,911Oct 24, 2018, 04:33 PM
LERNER RICHARD ADirectorSep 30, 2018 Option Exercise$21.7063313,73654,411Oct 02, 2018, 08:11 PM
RIGGS RORY BDirectorSep 30, 2018 Option Exercise$21.7066814,49638,784Oct 02, 2018, 08:08 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2018 Option Exercise$21.702685,8164,443Oct 02, 2018, 08:06 PM
Alafi Christopher DDirectorSep 30, 2018 Option Exercise$21.7066814,496747,643Oct 02, 2018, 08:01 PM
LERNER RICHARD ADirectorJun 29, 2018 Option Exercise$17.6777813,74753,778Jul 03, 2018, 04:27 PM
RIGGS RORY BDirectorJun 29, 2018 Option Exercise$17.6782014,48938,116Jul 03, 2018, 12:00 AM
Alafi Christopher DDirectorJun 29, 2018 Option Exercise$17.6782014,489746,975Jul 03, 2018, 12:00 AM
VAN NOSTRAND ROBERT LDirectorJun 29, 2018 Option Exercise$17.672824,9834,175Jul 03, 2018, 12:00 AM
VAN NOSTRAND ROBERT LDirectorMar 30, 2018 Option Exercise$21.052374,9893,893Apr 03, 2018, 04:19 PM
LERNER RICHARD ADirectorMar 30, 2018 Option Exercise$21.0565313,74610,223Apr 03, 2018, 12:00 AM
Alafi Christopher DDirectorMar 30, 2018 Option Exercise$21.0568814,482746,155Apr 03, 2018, 12:00 AM
RIGGS RORY BDirectorMar 30, 2018 Option Exercise$21.0568814,48237,296Apr 03, 2018, 12:00 AM
Hineline Lawrence J.VP of Finance CFOFeb 16, 2018 Sale$20.0116,319326,54317,032Feb 20, 2018, 04:38 PM
Hineline Lawrence J.VP of Finance CFOFeb 15, 2018 Sale$20.0333,381668,62133,351Feb 20, 2018, 04:38 PM
Halstead MichaelSVP and General CounselJan 22, 2018 Sale$18.0325,500459,765191Jan 24, 2018, 07:11 PM
Vanover Kimberly E.SVP, Clinical DevelopmentJan 08, 2018 Sale$17.4677213,47912,373Jan 10, 2018, 09:05 PM
Mates SharonChairman, President & CEOJan 08, 2018 Sale$17.486,604115,4381,088,707Jan 10, 2018, 09:01 PM
Mates SharonChairman, President & CEOJan 05, 2018 Sale$17.0811,257192,2701,095,311Jan 05, 2018, 08:19 PM
Vanover Kimberly E.SVP, Clinical DevelopmentJan 05, 2018 Sale$17.371,18520,58313,145Jan 05, 2018, 08:14 PM
Davis Robert ESVP, Chief Scientific OfficerJan 04, 2018 Sale$15.601,11517,39429,397Jan 05, 2018, 08:09 PM
Hineline Lawrence J.VP of Finance CFOJan 05, 2018 Sale$17.491,87032,70666,732Jan 05, 2018, 08:06 PM
Hineline Lawrence J.VP of Finance CFOJan 04, 2018 Sale$15.673,19250,01968,602Jan 05, 2018, 08:06 PM
Halstead MichaelSVP and General CounselJan 04, 2018 Sale$15.752,66041,89527,251Jan 05, 2018, 08:03 PM
Halstead MichaelSVP and General CounselJan 05, 2018 Sale$17.491,56027,28425,691Jan 05, 2018, 08:03 PM
VAN NOSTRAND ROBERT LDirectorDec 29, 2017 Option Exercise$14.483454,9963,656Jan 03, 2018, 06:10 PM
RIGGS RORY BDirectorDec 29, 2017 Option Exercise$14.481,00114,49436,608Jan 03, 2018, 06:05 PM
LERNER RICHARD ADirectorDec 29, 2017 Option Exercise$14.4894913,7429,570Jan 03, 2018, 06:01 PM
Alafi Christopher DDirectorDec 29, 2017 Option Exercise$14.481,00114,494745,467Jan 03, 2018, 05:59 PM
VAN NOSTRAND ROBERT LDirectorDec 29, 2017 Buy$14.483454,9963,656Jan 03, 2018, 04:31 PM
LERNER RICHARD ADirectorDec 29, 2017 Buy$14.4894913,7429,570Jan 03, 2018, 04:29 PM
RIGGS RORY BDirectorDec 29, 2017 Buy$14.481,00114,49436,608Jan 03, 2018, 12:00 AM
Alafi Christopher DDirectorDec 29, 2017 Buy$14.481,00114,494745,467Jan 03, 2018, 12:00 AM
LERNER RICHARD ADirectorDec 11, 2017 Option Exercise$1.5012,50018,75060,000Dec 13, 2017, 04:52 PM
LERNER RICHARD ADirectorDec 11, 2017 Sale$15.097,000105,63053,000Dec 13, 2017, 04:52 PM
Davis Robert ESVP, Chief Scientific OfficerDec 05, 2017 Sale$15.006509,75027,864Dec 06, 2017, 06:33 PM
Alafi Christopher DDirectorNov 22, 2017 Buy$15.5510,000155,500744,466Nov 27, 2017, 04:31 PM
Mates SharonChairman, President & CEOOct 30, 2017 Option Exercise$1.5018,75028,1251,107,457Nov 01, 2017, 08:04 PM
Mates SharonChairman, President & CEOOct 30, 2017 Sale$15.7518,750295,3131,088,707Nov 01, 2017, 08:04 PM
ALAFI MOSHE10% OwnerOct 02, 2017 Buy$15.50258,0654,000,0083,953,270Oct 03, 2017, 06:11 PM
Alafi Christopher DDirectorOct 02, 2017 Buy$15.50258,0654,000,0083,953,270Oct 03, 2017, 06:10 PM
ALAFI CAPITAL CO LLC10% OwnerOct 02, 2017 Buy$15.50258,0654,000,0083,953,270Oct 03, 2017, 06:08 PM
MARCUS JOEL SDirectorJan 26, 2017 Option Exercise$2.6095,000247,450116,671Jan 30, 2017, 06:13 PM
Vanover Kimberly E.SVP, Clinical DevelopmentJan 05, 2017 Sale$16.5980013,27210,128Jan 09, 2017, 05:34 PM
Mates SharonChairman, President & CEOJan 05, 2017 Sale$16.554,08167,5411,088,707Jan 09, 2017, 05:31 PM
Hineline Lawrence J.VP of Finance CFOJan 05, 2017 Sale$16.581,91831,80063,389Jan 09, 2017, 05:29 PM
Halstead MichaelSVP and General CounselJan 05, 2017 Sale$16.551,60126,49721,506Jan 09, 2017, 05:27 PM
Vanover Kimberly E.SVP, Clinical DevelopmentDec 15, 2016 Option Exercise$1.4618,75027,42512,500Dec 19, 2016, 05:50 PM
Vanover Kimberly E.SVP, Clinical DevelopmentDec 15, 2016 Sale$15.239,375142,7739,375Dec 19, 2016, 05:50 PM
ALAFI MOSHE10% OwnerDec 07, 2016 Buy$16.1420,826336,0383,695,205Dec 07, 2016, 04:35 PM
ALAFI MOSHE10% OwnerDec 06, 2016 Buy$16.3344,174721,4453,674,379Dec 07, 2016, 04:35 PM
Alafi Christopher DDirectorDec 06, 2016 Buy$16.3344,174721,4453,674,379Dec 07, 2016, 04:32 PM
Alafi Christopher DDirectorDec 07, 2016 Buy$16.1420,826336,0383,695,205Dec 07, 2016, 04:32 PM
ALAFI CAPITAL CO LLC10% OwnerDec 07, 2016 Buy$16.1420,826336,0383,695,205Dec 07, 2016, 04:21 PM
ALAFI CAPITAL CO LLC10% OwnerDec 06, 2016 Buy$16.3344,174721,4453,674,379Dec 07, 2016, 04:21 PM
ALAFI MOSHE10% OwnerNov 14, 2016 Buy$14.5034,000492,9693,630,205Nov 17, 2016, 04:35 PM
ALAFI CAPITAL CO LLC10% OwnerNov 14, 2016 Buy$14.5034,000492,9693,630,205Nov 17, 2016, 04:34 PM
Alafi Christopher DDirectorNov 14, 2016 Buy$14.5034,000492,9693,630,205Nov 17, 2016, 04:32 PM
RIGGS RORY BDirectorFeb 05, 2014 Buy$17.5014,285249,98826,091Apr 20, 2016, 04:30 PM
RIGGS RORY BDirectorFeb 05, 2014 Buy$17.5014,286250,005226,670Apr 20, 2016, 04:30 PM
Alafi Christopher DDirectorFeb 29, 2016 Buy$29.70100,0002,970,300728,828Feb 29, 2016, 05:32 PM
LERNER RICHARD ADirectorFeb 18, 2016 Option Exercise$1.3610,00013,60047,500Feb 19, 2016, 04:25 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2015 Option Exercise$53.79693,7121,365Jan 05, 2016, 07:09 PM
RIGGS RORY BDirectorDec 31, 2015 Option Exercise$53.7919710,59715,679Jan 05, 2016, 05:13 PM
MARCUS JOEL SDirectorDec 31, 2015 Option Exercise$53.7919910,70418,921Jan 05, 2016, 05:11 PM
Alafi Christopher DDirectorDec 31, 2015 Option Exercise$53.7919510,489628,828Jan 05, 2016, 05:00 PM
LERNER RICHARD ADirectorDec 31, 2015 Option Exercise$53.7918810,1133,266Jan 05, 2016, 04:59 PM
Mates SharonChairman, President & CEODec 11, 2015 Option Exercise$1.1268,75077,1251,137,685Dec 15, 2015, 08:27 PM
Mates SharonChairman, President & CEODec 11, 2015 Sale$53.8751,5002,774,4411,107,639Dec 15, 2015, 08:27 PM
Hineline Lawrence J.VP of Finance CFODec 14, 2015 Option Exercise$0.607,5004,50072,200Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFONov 24, 2015 Option Exercise$0.605,0003,00064,700Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFODec 15, 2015 Option Exercise$1.4535,00050,75074,700Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFODec 14, 2015 Sale$50.9422,5001,146,14062,307Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFODec 15, 2015 Sale$51.9722,5001,169,22663,464Dec 15, 2015, 08:25 PM
MARCUS JOEL SDirectorDec 04, 2015 Sale$55.9630,0001,678,8001,253,856Dec 08, 2015, 05:30 PM
MARCUS JOEL SDirectorDec 08, 2015 Sale$54.8022,7001,243,9601,191,156Dec 08, 2015, 05:30 PM
MARCUS JOEL SDirectorDec 07, 2015 Sale$53.1740,0002,126,6281,238,781Dec 08, 2015, 05:30 PM
Hineline Lawrence J.VP of Finance CFONov 24, 2015 Sale$55.005,000275,00059,700Nov 27, 2015, 08:29 AM
Fienberg Allen A.VP of Business DevelopmentSep 09, 2015 Option Exercise$1.3612,50017,000295,000Sep 11, 2015, 04:53 PM
Fienberg Allen A.VP of Business DevelopmentAug 21, 2015 Sale$30.302006,060197,823Sep 11, 2015, 04:53 PM
Fienberg Allen A.VP of Business DevelopmentAug 19, 2015 Sale$30.3010,000303,000198,023Sep 11, 2015, 04:53 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryJun 08, 2015 Sale$26.8425,000671,000126,500Jun 09, 2015, 05:04 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryMay 19, 2015 Option Exercise$1.2347,50058,250151,500May 20, 2015, 05:19 PM
Fienberg Allen A.VP of Business DevelopmentMar 31, 2015 Option Exercise$0.6012,5007,500282,500Apr 02, 2015, 04:59 PM
MARCUS JOEL SDirectorMar 31, 2015 Option Exercise$1.2315,00018,40018,118Apr 02, 2015, 04:58 PM
Alafi Christopher DDirectorMar 11, 2015 Buy$24.00625,00015,000,000627,604Mar 12, 2015, 06:24 PM
Fienberg Allen A.VP of Business DevelopmentJan 14, 2015 Sale$19.005,00095,000270,000Jan 16, 2015, 04:31 PM
Hineline Lawrence J.VP of Finance CFODec 08, 2014 Sale$16.9110,965185,41876,235Dec 10, 2014, 05:11 PM
Hineline Lawrence J.VP of Finance CFODec 09, 2014 Sale$16.5211,535190,55864,700Dec 10, 2014, 05:11 PM
Hineline Lawrence J.VP of Finance CFODec 02, 2014 Option Exercise$0.5037,20018,60087,200Dec 03, 2014, 05:43 PM
Alafi Christopher DDirectorDec 01, 2014 Buy$14.751,42220,9753,596,205Dec 03, 2014, 05:42 PM
ALAFI MOSHE10% OwnerDec 01, 2014 Buy$14.751,42220,9753,596,205Dec 03, 2014, 05:40 PM
ALAFI CAPITAL CO LLC10% OwnerDec 01, 2014 Buy$14.751,42220,9753,596,205Dec 03, 2014, 05:39 PM
ALAFI CAPITAL CO LLC10% OwnerNov 28, 2014 Buy$14.7535,000516,2503,594,783Nov 28, 2014, 04:42 PM
ALAFI MOSHE10% OwnerNov 28, 2014 Buy$14.7535,000516,2503,594,783Nov 28, 2014, 04:38 PM
Alafi Christopher DDirectorNov 28, 2014 Buy$14.7535,000516,2503,594,783Nov 28, 2014, 04:36 PM
Mates SharonChairman, President & CEONov 25, 2014 Option Exercise$0.5050,00025,0001,103,935Nov 28, 2014, 04:31 PM
Mates SharonChairman, President & CEONov 28, 2014 Sale$14.7535,000516,2501,068,935Nov 28, 2014, 04:31 PM
Alafi Christopher DDirectorNov 19, 2014 Buy$14.251,03414,7353,559,783Nov 21, 2014, 06:04 PM
ALAFI MOSHE10% OwnerNov 19, 2014 Buy$14.251,03414,7353,559,783Nov 21, 2014, 06:00 PM
ALAFI CAPITAL CO LLC10% OwnerNov 19, 2014 Buy$14.251,03414,7353,559,783Nov 21, 2014, 05:58 PM
Alafi Christopher DDirectorNov 18, 2014 Buy$14.233,53150,2463,558,749Nov 18, 2014, 05:46 PM
Alafi Christopher DDirectorNov 14, 2014 Buy$15.071332,0043,555,218Nov 18, 2014, 05:46 PM
ALAFI MOSHE10% OwnerNov 18, 2014 Buy$14.233,53150,2463,558,749Nov 18, 2014, 05:45 PM
ALAFI MOSHE10% OwnerNov 14, 2014 Buy$15.071332,0043,555,218Nov 18, 2014, 05:45 PM
ALAFI CAPITAL CO LLC10% OwnerNov 18, 2014 Buy$14.233,53150,2463,558,749Nov 18, 2014, 05:43 PM
ALAFI CAPITAL CO LLC10% OwnerNov 14, 2014 Buy$15.071332,0043,555,218Nov 18, 2014, 05:43 PM
Alafi Christopher DDirectorNov 12, 2014 Buy$15.235,00076,1503,552,885Nov 13, 2014, 05:04 PM
Alafi Christopher DDirectorNov 11, 2014 Buy$15.555,00077,7503,547,885Nov 13, 2014, 05:04 PM
Alafi Christopher DDirectorNov 13, 2014 Buy$15.122,20033,2643,555,085Nov 13, 2014, 05:04 PM
ALAFI MOSHE10% OwnerNov 13, 2014 Buy$15.122,20033,2643,555,085Nov 13, 2014, 05:01 PM
ALAFI MOSHE10% OwnerNov 12, 2014 Buy$15.235,00076,1503,552,885Nov 13, 2014, 05:01 PM
ALAFI MOSHE10% OwnerNov 11, 2014 Buy$15.555,00077,7503,547,885Nov 13, 2014, 05:01 PM
ALAFI CAPITAL CO LLC10% OwnerNov 11, 2014 Buy$15.555,00077,7503,547,885Nov 13, 2014, 04:59 PM
ALAFI CAPITAL CO LLC10% OwnerNov 13, 2014 Buy$15.122,20033,2643,555,085Nov 13, 2014, 04:59 PM
ALAFI CAPITAL CO LLC10% OwnerNov 12, 2014 Buy$15.235,00076,1503,552,885Nov 13, 2014, 04:59 PM
Halstead MichaelSVP and General CounselNov 06, 2014 Buy$15.4713,000201,11020,000Nov 06, 2014, 04:53 PM
Halstead MichaelSVP and General CounselNov 05, 2014 Buy$15.217,000106,4707,000Nov 06, 2014, 04:53 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 16, 2014 Sale$15.005,15277,280104,000Oct 17, 2014, 05:00 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 15, 2014 Sale$15.002,00430,060109,152Oct 15, 2014, 04:52 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 13, 2014 Sale$15.001,60024,000111,156Oct 15, 2014, 04:52 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 08, 2014 Sale$15.004,74571,175112,756Oct 10, 2014, 05:05 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 06, 2014 Sale$15.006369,540117,501Oct 07, 2014, 04:30 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 03, 2014 Sale$15.0015,863237,945118,137Oct 07, 2014, 04:30 PM
Wennogle Lawrence P.Vice President, Drug DiscoverySep 15, 2014 Sale$15.005,00075,000134,000Sep 17, 2014, 05:12 PM
Hineline Lawrence J.VP of Finance CFOSep 08, 2014 Option Exercise$0.5030015050,300Sep 10, 2014, 05:33 PM
Hineline Lawrence J.VP of Finance CFOSep 08, 2014 Sale$15.003004,50050,000Sep 10, 2014, 05:33 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryJul 21, 2014 Option Exercise$0.5037,50018,750139,000Jul 22, 2014, 05:31 PM
ALAFI MOSHE10% OwnerJun 19, 2014 Sale$6.3515,742100,0060Jul 10, 2014, 04:56 PM
Fienberg Allen A.VP of Business DevelopmentMay 28, 2014 Option Exercise$0.5037,50018,750275,000Jun 06, 2014, 05:23 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryMay 27, 2014 Sale$15.005,00075,000101,500May 29, 2014, 06:30 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryMay 22, 2014 Sale$15.006,00089,983110,806May 23, 2014, 07:46 PM
RIGGS RORY BDirectorFeb 05, 2014 Buy$17.5028,571499,993240,955Feb 05, 2014, 04:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
VAN NOSTRAND ROBERT LDirector12/30/20225,133
RIGGS RORY BDirector12/30/202216,987
MARCUS JOEL SDirector12/19/2022254,100
Mates SharonChairman, President & CEO12/13/20221,819,565
Halstead MichaelEVP and General Counsel12/01/2022773,500
Halstead MichaelEVP and General Counsel12/01/20222,686,514
MARCUS JOEL SDirector11/07/2022523,023
VAN NOSTRAND ROBERT LDirector09/30/20225,118
RIGGS RORY BDirector09/30/202216,983
Hineline Lawrence J.SVP of Finance CFO09/21/20221,008,087
Hineline Lawrence J.SVP of Finance CFO09/21/20222,973,406
VAN NOSTRAND ROBERT LDirector08/11/2022379,500
VAN NOSTRAND ROBERT LDirector08/11/20221,713,975
MARCUS JOEL SDirector08/11/2022592,200
RIGGS RORY BDirector06/30/202216,496
MARCUS JOEL SDirector05/12/2022550,000
Neumann MarkEVP, Chief Commercial Officer04/08/20221,099,210
Neumann MarkEVP, Chief Commercial Officer04/08/20225,558,051
VAN NOSTRAND ROBERT LDirector03/31/20227,710
RIGGS RORY BDirector03/31/202215,726
RIGGS RORY BDirector03/18/20221,262,505
RIGGS RORY BDirector03/17/20228,536,646
RIGGS RORY BDirector03/16/20223,824,827
Mates SharonChairman, President & CEO03/09/2022110,547
MARCUS JOEL SDirector03/08/2022790,150
MARCUS JOEL SDirector03/07/2022272,600
Durgam Suresh K.Chief Medical Officer03/04/2022214,307
Durgam Suresh K.Chief Medical Officer03/02/2022238,005
Durgam Suresh K.Chief Medical Officer02/24/2022211,468
Neumann MarkEVP, Chief Commercial Officer02/24/2022412,810
Halstead MichaelEVP and General Counsel02/24/2022410,933
Hineline Lawrence J.SVP of Finance CFO02/24/2022387,349
Mates SharonChairman, President & CEO02/24/20221,174,074
Durgam Suresh K.Chief Medical Officer02/22/2022230,958
Neumann MarkEVP, Chief Commercial Officer02/22/2022615,827
Halstead MichaelEVP and General Counsel02/22/2022617,100
Hineline Lawrence J.SVP of Finance CFO02/22/2022578,506
Mates SharonChairman, President & CEO02/22/20221,542,413
Durgam Suresh K.Chief Medical Officer01/18/2022261,553
Durgam Suresh K.Chief Medical Officer01/10/2022280,020
Neumann MarkEVP, Chief Commercial Officer01/10/2022854,255
Halstead MichaelEVP and General Counsel01/10/2022800,774
Hineline Lawrence J.SVP of Finance CFO01/10/2022800,420
Mates SharonChairman, President & CEO01/10/20221,708,429
VAN NOSTRAND ROBERT LDirector12/31/20217,746
RIGGS RORY BDirector12/31/202115,702
Halstead MichaelEVP and General Counsel12/21/20212,897,494
Halstead MichaelEVP and General Counsel12/21/20218,412,278
Hineline Lawrence J.SVP of Finance CFO12/21/20212,941,951
Hineline Lawrence J.SVP of Finance CFO12/21/20218,328,664
Neumann MarkEVP, Chief Commercial Officer10/18/2021549,551
Mates SharonChairman, President & CEO10/15/20213,053
Mates SharonChairman, President & CEO10/18/2021327,680
Mates SharonChairman, President & CEO10/15/20211,615,680
Mates SharonChairman, President & CEO10/14/202156,640
LERNER RICHARD ADirector09/30/202114,987
RIGGS RORY BDirector09/30/202115,732
VAN NOSTRAND ROBERT LDirector09/30/20218,015
Mates SharonChairman, President & CEO08/23/202128,400
VAN NOSTRAND ROBERT LDirector06/30/20217,062
RIGGS RORY BDirector06/30/202115,716
LERNER RICHARD ADirector06/30/202114,981
Alafi Christopher DDirector05/24/20211,075,490
Alafi Christopher DDirector05/21/202144,000
LERNER RICHARD ADirector03/31/202114,997
MARCUS JOEL SDirector03/02/2021531,600
MARCUS JOEL SDirector03/02/2021532,683
Durgam Suresh K.Chief Medical Officer02/19/2021107,310
Neumann MarkEVP, Chief Commercial Officer02/19/2021203,308
Hineline Lawrence J.SVP of Finance CFO02/19/2021409,625
Halstead MichaelEVP and General Counsel02/19/2021437,133
Mates SharonChairman, President & CEO02/19/20211,092,436
Durgam Suresh K.Chief Medical Officer01/11/2021140,259
Neumann MarkEVP, Chief Commercial Officer01/11/2021310,082
Hineline Lawrence J.SVP of Finance CFO01/11/2021628,769
Halstead MichaelEVP and General Counsel01/11/2021628,978
Mates SharonChairman, President & CEO01/11/20211,341,260
Hineline Lawrence J.SVP of Finance CFO01/04/2021495,008
Halstead MichaelEVP and General Counsel01/04/2021505,834
Mates SharonChairman, President & CEO01/04/20211,513,271
LERNER RICHARD ADirector12/31/202014,978
VAN NOSTRAND ROBERT LDirector12/31/20207,060
RIGGS RORY BDirector12/31/202015,741
Alafi Christopher DDirector12/31/202015,741
Mates SharonChairman, President & CEO12/18/202093,160
Halstead MichaelEVP and General Counsel11/17/20201,039,500
Halstead MichaelEVP and General Counsel11/17/20202,193,446
Hineline Lawrence J.SVP of Finance CFO11/11/202061,000
Hineline Lawrence J.SVP of Finance CFO11/11/2020712,344
Mates SharonChairman, President & CEO11/10/20201,317,101
Mates SharonChairman, President & CEO11/04/20201,250,000
Neumann MarkEVP, Chief Commercial Officer10/16/2020182,026
VAN NOSTRAND ROBERT LDirector09/30/20207,082
RIGGS RORY BDirector09/30/202015,730
LERNER RICHARD ADirector09/30/202014,985
Alafi Christopher DDirector09/30/202015,730
Alafi Christopher DDirector09/14/20201,465,200
Hineline Lawrence J.SVP of Finance CFO09/09/2020343,494
Hineline Lawrence J.SVP of Finance CFO09/09/20201,307,351
Alafi Christopher DDirector09/11/2020589,680
VAN NOSTRAND ROBERT LDirector06/30/20207,059
LERNER RICHARD ADirector06/30/202014,991
RIGGS RORY BDirector06/30/202015,736
Alafi Christopher DDirector06/30/202015,736
MARCUS JOEL SDirector05/14/2020192,424
MARCUS JOEL SDirector05/11/2020997,500
MARCUS JOEL SDirector05/13/2020150,537
LERNER RICHARD ADirector05/11/202068,500
LERNER RICHARD ADirector05/11/202071,750
Alafi Christopher DDirector03/31/202015,739
LERNER RICHARD ADirector03/31/202014,986
VAN NOSTRAND ROBERT LDirector03/31/20207,070
RIGGS RORY BDirector03/31/202015,739
Halstead MichaelEVP and General Counsel01/24/202089,930
Hineline Lawrence J.SVP of Finance CFO01/24/202089,930
Mates SharonChairman, President & CEO01/24/2020220,116
LERNER RICHARD ADirector12/31/201913,724
Satlin AndrewEVP and Chief Medical Officer01/09/2020302,750
Neumann MarkEVP, Chief Commercial Officer01/08/2020162,175
Mates SharonChairman, President & CEO01/09/20201,095,973
Halstead MichaelEVP and General Counsel01/09/2020513,730
Hineline Lawrence J.SVP of Finance CFO01/09/2020513,730
Mates SharonChairman, President & CEO01/08/2020164,400
Mates SharonChairman, President & CEO01/06/20201,380,880
Halstead MichaelEVP and General Counsel01/06/2020651,007
Hineline Lawrence J.SVP of Finance CFO01/06/2020650,003
Halstead MichaelEVP and General Counsel01/02/2020253,214
Hineline Lawrence J.SVP of Finance CFO01/02/2020253,165
Mates SharonChairman, President & CEO12/31/201916,440
Mates SharonChairman, President & CEO01/02/2020567,230
VAN NOSTRAND ROBERT LDirector12/31/20195,833
RIGGS RORY BDirector12/31/201914,479
Alafi Christopher DDirector12/31/201914,479
Hineline Lawrence J.SVP of Finance CFO12/23/201926,304
Hineline Lawrence J.SVP of Finance CFO12/23/2019383,316
Neumann MarkEVP, Chief Commercial Officer10/16/201955,886
RIGGS RORY BDirector09/30/201914,499
LERNER RICHARD ADirector09/30/201913,745
VAN NOSTRAND ROBERT LDirector09/30/20195,827
Alafi Christopher DDirector09/30/201914,499
Alafi Christopher DDirector09/10/20194,974,678
Alafi Christopher DDirector08/30/20191,065,212
VAN NOSTRAND ROBERT LDirector06/28/20195,828
LERNER RICHARD ADirector06/28/201913,746
RIGGS RORY BDirector06/28/201914,499
Alafi Christopher DDirector06/28/201914,499
Alafi Christopher DDirector11/22/2017155,500
Alafi Christopher DDirector06/12/20191,993,793
MARCUS JOEL SDirector05/29/2019249,000
Alafi Christopher DDirector05/14/20191,256,350
Alafi Christopher DDirector03/31/201914,494
VAN NOSTRAND ROBERT LDirector03/31/20195,822
RIGGS RORY BDirector03/31/201914,494
LERNER RICHARD ADirector03/31/201913,739
Hineline Lawrence J.SVP of Finance CFO02/27/201928,496
Hineline Lawrence J.SVP of Finance CFO02/27/201915,000
Mates SharonChairman, President & CEO01/07/201982,088
Mates SharonChairman, President & CEO01/04/2019522,222
Halstead MichaelEVP and General Counsel01/04/2019245,817
Halstead MichaelEVP and General Counsel01/07/201938,601
Hineline Lawrence J.SVP of Finance CFO01/07/201938,601
Hineline Lawrence J.SVP of Finance CFO01/04/2019245,782
Vanover Kimberly E.SVP, Early Stage Clinical Dev.01/07/20197,276
Vanover Kimberly E.SVP, Early Stage Clinical Dev.01/04/2019109,704
Davis Robert ESVP, Chief Scientific Officer01/04/2019109,630
Mates SharonChairman, President & CEO01/02/2019193,831
Halstead MichaelEVP and General Counsel01/02/201986,580
Vanover Kimberly E.SVP, Early Stage Clinical Dev.01/02/201953,657
Davis Robert ESVP, Chief Scientific Officer01/02/201953,706
Hineline Lawrence J.SVP of Finance CFO01/02/201986,580
VAN NOSTRAND ROBERT LDirector12/31/20185,832
RIGGS RORY BDirector12/31/201814,499
LERNER RICHARD ADirector12/31/201813,748
Alafi Christopher DDirector12/31/201814,499
Mates SharonChairman, President & CEO12/10/201875,000
Davis Robert ESVP, Chief Scientific Officer12/06/201812,163
MARCUS JOEL SDirector11/12/2018125,580
MARCUS JOEL SDirector11/09/2018456,000
LERNER RICHARD ADirector10/22/201818,750
LERNER RICHARD ADirector09/30/201813,736
RIGGS RORY BDirector09/30/201814,496
VAN NOSTRAND ROBERT LDirector09/30/20185,816
Alafi Christopher DDirector09/30/201814,496
LERNER RICHARD ADirector06/29/201813,747
RIGGS RORY BDirector06/29/201814,489
Alafi Christopher DDirector06/29/201814,489
VAN NOSTRAND ROBERT LDirector06/29/20184,983
VAN NOSTRAND ROBERT LDirector03/30/20184,989
LERNER RICHARD ADirector03/30/201813,746
Alafi Christopher DDirector03/30/201814,482
RIGGS RORY BDirector03/30/201814,482
Hineline Lawrence J.VP of Finance CFO02/16/2018326,543
Hineline Lawrence J.VP of Finance CFO02/15/2018668,621
Halstead MichaelSVP and General Counsel01/22/2018459,765
Vanover Kimberly E.SVP, Clinical Development01/08/201813,479
Mates SharonChairman, President & CEO01/08/2018115,438
Mates SharonChairman, President & CEO01/05/2018192,270
Vanover Kimberly E.SVP, Clinical Development01/05/201820,583
Davis Robert ESVP, Chief Scientific Officer01/04/201817,394
Hineline Lawrence J.VP of Finance CFO01/05/201832,706
Hineline Lawrence J.VP of Finance CFO01/04/201850,019
Halstead MichaelSVP and General Counsel01/04/201841,895
Halstead MichaelSVP and General Counsel01/05/201827,284
VAN NOSTRAND ROBERT LDirector12/29/20174,996
RIGGS RORY BDirector12/29/201714,494
LERNER RICHARD ADirector12/29/201713,742
Alafi Christopher DDirector12/29/201714,494
VAN NOSTRAND ROBERT LDirector12/29/20174,996
LERNER RICHARD ADirector12/29/201713,742
RIGGS RORY BDirector12/29/201714,494
Alafi Christopher DDirector12/29/201714,494
LERNER RICHARD ADirector12/11/201718,750
LERNER RICHARD ADirector12/11/2017105,630
Davis Robert ESVP, Chief Scientific Officer12/05/20179,750
Alafi Christopher DDirector11/22/2017155,500
Mates SharonChairman, President & CEO10/30/201728,125
Mates SharonChairman, President & CEO10/30/2017295,313
ALAFI MOSHE10% Owner10/02/20174,000,008
Alafi Christopher DDirector10/02/20174,000,008
ALAFI CAPITAL CO LLC10% Owner10/02/20174,000,008
MARCUS JOEL SDirector01/26/2017247,450
Vanover Kimberly E.SVP, Clinical Development01/05/201713,272
Mates SharonChairman, President & CEO01/05/201767,541
Hineline Lawrence J.VP of Finance CFO01/05/201731,800
Halstead MichaelSVP and General Counsel01/05/201726,497
Vanover Kimberly E.SVP, Clinical Development12/15/201627,425
Vanover Kimberly E.SVP, Clinical Development12/15/2016142,773
ALAFI MOSHE10% Owner12/07/2016336,038
ALAFI MOSHE10% Owner12/06/2016721,445
Alafi Christopher DDirector12/06/2016721,445
Alafi Christopher DDirector12/07/2016336,038
ALAFI CAPITAL CO LLC10% Owner12/07/2016336,038
ALAFI CAPITAL CO LLC10% Owner12/06/2016721,445
ALAFI MOSHE10% Owner11/14/2016492,969
ALAFI CAPITAL CO LLC10% Owner11/14/2016492,969
Alafi Christopher DDirector11/14/2016492,969
RIGGS RORY BDirector02/05/2014249,988
RIGGS RORY BDirector02/05/2014250,005
Alafi Christopher DDirector02/29/20162,970,300
LERNER RICHARD ADirector02/18/201613,600
VAN NOSTRAND ROBERT LDirector12/31/20153,712
RIGGS RORY BDirector12/31/201510,597
MARCUS JOEL SDirector12/31/201510,704
Alafi Christopher DDirector12/31/201510,489
LERNER RICHARD ADirector12/31/201510,113
Mates SharonChairman, President & CEO12/11/201577,125
Mates SharonChairman, President & CEO12/11/20152,774,441
Hineline Lawrence J.VP of Finance CFO12/14/20154,500
Hineline Lawrence J.VP of Finance CFO11/24/20153,000
Hineline Lawrence J.VP of Finance CFO12/15/201550,750
Hineline Lawrence J.VP of Finance CFO12/14/20151,146,140
Hineline Lawrence J.VP of Finance CFO12/15/20151,169,226
MARCUS JOEL SDirector12/04/20151,678,800
MARCUS JOEL SDirector12/08/20151,243,960
MARCUS JOEL SDirector12/07/20152,126,628
Hineline Lawrence J.VP of Finance CFO11/24/2015275,000
Fienberg Allen A.VP of Business Development09/09/201517,000
Fienberg Allen A.VP of Business Development08/21/20156,060
Fienberg Allen A.VP of Business Development08/19/2015303,000
Wennogle Lawrence P.Vice President, Drug Discovery06/08/2015671,000
Wennogle Lawrence P.Vice President, Drug Discovery05/19/201558,250
Fienberg Allen A.VP of Business Development03/31/20157,500
MARCUS JOEL SDirector03/31/201518,400
Alafi Christopher DDirector03/11/201515,000,000
Fienberg Allen A.VP of Business Development01/14/201595,000
Hineline Lawrence J.VP of Finance CFO12/08/2014185,418
Hineline Lawrence J.VP of Finance CFO12/09/2014190,558
Hineline Lawrence J.VP of Finance CFO12/02/201418,600
Alafi Christopher DDirector12/01/201420,975
ALAFI MOSHE10% Owner12/01/201420,975
ALAFI CAPITAL CO LLC10% Owner12/01/201420,975
ALAFI CAPITAL CO LLC10% Owner11/28/2014516,250
ALAFI MOSHE10% Owner11/28/2014516,250
Alafi Christopher DDirector11/28/2014516,250
Mates SharonChairman, President & CEO11/25/201425,000
Mates SharonChairman, President & CEO11/28/2014516,250
Alafi Christopher DDirector11/19/201414,735
ALAFI MOSHE10% Owner11/19/201414,735
ALAFI CAPITAL CO LLC10% Owner11/19/201414,735
Alafi Christopher DDirector11/18/201450,246
Alafi Christopher DDirector11/14/20142,004
ALAFI MOSHE10% Owner11/18/201450,246
ALAFI MOSHE10% Owner11/14/20142,004
ALAFI CAPITAL CO LLC10% Owner11/18/201450,246
ALAFI CAPITAL CO LLC10% Owner11/14/20142,004
Alafi Christopher DDirector11/12/201476,150
Alafi Christopher DDirector11/11/201477,750
Alafi Christopher DDirector11/13/201433,264
ALAFI MOSHE10% Owner11/13/201433,264
ALAFI MOSHE10% Owner11/12/201476,150
ALAFI MOSHE10% Owner11/11/201477,750
ALAFI CAPITAL CO LLC10% Owner11/11/201477,750
ALAFI CAPITAL CO LLC10% Owner11/13/201433,264
ALAFI CAPITAL CO LLC10% Owner11/12/201476,150
Halstead MichaelSVP and General Counsel11/06/2014201,110
Halstead MichaelSVP and General Counsel11/05/2014106,470
Wennogle Lawrence P.Vice President, Drug Discovery10/16/201477,280
Wennogle Lawrence P.Vice President, Drug Discovery10/15/201430,060
Wennogle Lawrence P.Vice President, Drug Discovery10/13/201424,000
Wennogle Lawrence P.Vice President, Drug Discovery10/08/201471,175
Wennogle Lawrence P.Vice President, Drug Discovery10/06/20149,540
Wennogle Lawrence P.Vice President, Drug Discovery10/03/2014237,945
Wennogle Lawrence P.Vice President, Drug Discovery09/15/201475,000
Hineline Lawrence J.VP of Finance CFO09/08/2014150
Hineline Lawrence J.VP of Finance CFO09/08/20144,500
Wennogle Lawrence P.Vice President, Drug Discovery07/21/201418,750
ALAFI MOSHE10% Owner06/19/2014100,006
Fienberg Allen A.VP of Business Development05/28/201418,750
Wennogle Lawrence P.Vice President, Drug Discovery05/27/201475,000
Wennogle Lawrence P.Vice President, Drug Discovery05/22/201489,983
RIGGS RORY BDirector02/05/2014499,993
Load More Insider Transactions